ELOVL6 and metabolic dysfunction-associated steatotic liver disease: Different studies indicate that the development of NAFLD is a result of insulin resistance, while liver fatty acids and the expression level of ELOVL6 (an enzyme that regulates fatty acid composition) are responsible for the development of insulin resistance [47] and liver tissue fibrosis [48].